Work

Abstract PD6-02: The genomics of response to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer – Results from the ACOSOG Z1041 (Alliance) trial

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs15-pd6-02

Authors: R Lesurf, O Griffith, M Griffith, MA Watson, J Hoog, MJ Ellis, D Ota, VJ Suman, F Meric-Bernstam, AM Leitch, JC Boughey, G Unzeitig, AU Buzdar, KK Hunt, ER Mardis

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Doctors Hospital of Laredo, Duke Medical Center, The University of Texas Southwestern Medical Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2404058587

Cites:

Cited by:

Related to: 10